Antidepressant-like effects of 1-aminocyclopropanecarboxylic acid and D-cycloserine in an animal model of depression

European Journal of Pharmacology

Volumn 316, Issue 2-3, 1996, Pages 145-151

  Papp, Mariusz ^a   Moryl, Elzbieta ^a  

^a INSTITUTE OF PHARMACOLOGY   (Poland)

Author keywords

ACPC (1 aminocyclopropanecarboxylic acid); Anhedonia; Antidepressant action; Chronic; D cycloserine; Imipramine; Stress

Indexed keywords

1 AMINOCYCLOPROPANECARBOXYLIC ACID; CYCLOSERINE; IMIPRAMINE;

ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DEPRESSION; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; STRESS;

ANIMALS; BODY WEIGHT; CARBOXYLIC ACIDS; CYCLOSERINE; DEPRESSIVE DISORDER; DISEASE MODELS, ANIMAL; DRINKING; MALE; RATS; RATS, WISTAR;

EID: 0030571516     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(96)00675-9     Document Type: Article

References (46)

1. American Psychiatric Association, 1987, DSM II R - Diagnostic and Manual of Psychiatric Disorders, 3rd ed., revised (APA, Washington, DC).
2. Anthony, E.W. and M.E. Nevins, 1993, Anxiolytic-like effects of N-methyl-D-aspartate-associated glycine receptor ligands in the rat potentiated startle test, Eur. J. Pharmacol. 250, 317.
3. Baran, H., W. Löscher and M. Mevissen, 1994, The glycine/NMDA receptor partial agonist D-cycloserine blocks kainate-induced seizures in rats. Comparison with MK-801 and diazepam, Brain Res. 652, 195.
4. Borsini, F. and A. Meli, 1988, Is the forced swimming test a suitable model for revealing antidepressant activity?. Psychopharmacology 94, 147.
5. Caldecott-Hazard, S., D.G. Morgan, F. DeLeon-Jones, D.H. Overstreet and D. Janowsky, 1991, Clinical and biochemical aspects of depressive disorders: II. Transmitter/receptor theories, Synapse 8, 185.
6. Cherkofsky, S.C., 1995, 1-aminocyclopropanecarboxylic acid: Mouse to man interspecies pharmacokinetic comparisons and allometric relationships, J. Pharm. Sci. 84, 1231.
7. Faiman, C.P., E. Viu, P. Skolnick and R. Trullas, 1994, Different effects of compounds that act at strychnine-insensitive glycine receptors in a punishment procedure, J. Pharmacol. Exp. Ther. 270, 528.
8. Fossom, L.H., D.K.J.E. Von Lubitz, R.C.S. Lin and P. Skolnick, 1995, Neuroprotective actions of 1-aminocyclopropanecarboxylic acid (ACPC): A partial agonist at strychnine-insensitive glycine sites, Neurol. Res. 17, 265.
9. Grotta, J., W. Clark, B. Coull, L.C. Pettigrew, B. Mackay, L.B. Goldstein, I. Meissner, D. Murphy and L. Laure, 1995, Safety and tolerability of the glutamate antagonist CGS 19755 (selfotel) in patients with acute ischemic stroke. Results of a phase IIa randomized trial, Stroke 26, 602.
10. Henderson, G., J.W. Johnson and P. Ascher, 1990, Competitive antagonists and partial agonists at the glycine modulatory site of the mouse N-methyl-D-aspartate receptor, J. Physiol. 430, 189.
11. Hood, W.F., R.P. Compton and J.B. Monahan, 1989, D-cycloserine: A ligand for the N-methyl-D-aspartate coupled glycine receptor has partial agonist characteristics, Neurosci. Lett. 98, 91.
12. Kahn, R.S. and H.M. Van Praag, 1992, Panic disorder: A biological perspective, Eur. Neuropsychopharmacol. 2, 1.
13. Kleckner, N.W. and R. Dingledine, 1988, Requirement for glycine in activation of NMDA-receptors expressed in Xenopus oocytes, Science 241, 835.
14. 2 receptors in the chronic mild stress model of depression in rats, Pol. J. Pharmacol. 46, 67.
15. Layer, R.T., P. Popik, T. Olds and P. Skolnick, 1995, Antidepressant-like action of the polyamine site NMDA antagonist, eliprodil (SL-82.0715), Pharmacol. Biochem. Behav. 52, 621.
16. Long, J.B. and P. Skolnick, 1994, 1-aminocyclopropanecarboxylic acid protects against dynorphine A-induced spinal injury, Eur. J. Pharmacol. 261, 295.
17. Maj, J., Z. Rogoz, G. Skuza and H. Sowinska, 1992a, Effects of MK-801 and antidepressant drugs in the forced swimming test in rats, Eur. Neuropsychopharmacol. 2, 37.
18. Maj, J., Z. Rogoz, G. Skuza and H. Sowinska, 1992b, The effect of CGP 37849 and CGP 39551, competitive NMDA receptor antagonists, in the forced swimming test, Pol. J. Pharmacol. 44, 337.
19. Maj, J., Z. Rogoz, G. Skuza and K. Kolodziejczyk, 1994, Some central effects of kynurenic acid, 7-chlorokynurenic acid and 5,7-dichlorokynurenic acid, glycine site antagonists, Pol. J. Pharmacol. 46, 115.
20. Moreau, J.-L., F. Jenck, J.R. Martin, P. Mortas and W.E. Haefely, 1992, Antidepressant treatment prevents chronic unpredictable mild stress-induced anhedonia as assessed by ventral tegmentum self-stimulation behavior in rats, Eur. Neuropsychopharmacol. 2, 43.
21. Moryl, E., W. Danysz and G. Quack, 1993, Potential antidepressive properties of amantadine, memantine and bifemelane, Pharmacol. Toxicol. 72, 394.
22. Muscat, R., M. Papp and P. Willner, 1992, Reversal of stress-induced anhedonia by the atypical antidepressants, fluoxetine and maprotiline, Psychopharmacology 109, 433.
23. Nowak, G., R. Trullas, R. Layer, P. Skolnick and I.A. Paul, 1993, Adaptive changes in the N-methyl-D-aspartate receptor complex following chronic treatment with imipramine and 1-aminocyclopropanecarboxylic acid, J. Pharmacol. Exp. Ther. 265, 1380.
24. Papp, M., P. Willner and R. Muscat, 1991, An animal model of anhedonia: Attenuation of sucrose consumption and place preference conditioning by chronic unpredictable mild stress, Psychopharmacology 104, 255.
25. Papp, M., S. Lappas, R. Muscat and P. Willner, 1992, Attenuation of place preference conditioning but not place aversion conditioning by chronic mild stress, J. Psychopharmacol. 6, 352.
26. Papp, M., R. Muscat and P. Willner, 1993, Subsensitivity to rewarding and locomotor stimulant effects of a dopamine agonist following chronic mild stress. Psychopharmacology 110, 152.
27. Papp, M. and E. Moryl, 1994, Antidepressant activity of non-competitive and competitive NMDA receptor antagonists in a chronic mild stress model of depression, Eur. J. Pharmacol. 263, 1.
28. Papp, M., E. Moryl and P. Willner, 1996, Pharmacological validation of the chronic mild stress model of depression, Eur. J. Pharmacol. 296, 129.
29. Patat, A., P. Molinier, T. Hergueta, S. Brohier, I. Zieleniuk, P. Danjou, D. Warot and A. Puech, 1994, Lack of amnestic, psychomimetic or impairing effect on psychomotor performance of eliprodil, a new NMDA antagonist, Int. Clin. Psychopharm. 9, 155.
30. Paul, I.A., R. Trullas, P. Skolnick and G. Nowak, 1992, Down-regulation of cortical β-adrenoceptors by chronic treatment with functional NMDA antagonists, Psychopharmacology 106, 285.
31. Paul, I., G. Nowak, R.T. Layer, P. Popik and P. Skolnick, 1994, Adaptation of the N-methyl-D-aspartate receptor complex following chronic antidepressant treatments, J. Pharmacol. Exp. Ther. 269, 95.
32. Pillard, R.C. and S. Fisher, 1978, Normal humans as models for psychopharmacologic therapy, in: Psychopharmacology: A Generation of Progress, eds. M.A. Lipton, A. Di Mascio and K.F. Kiliam (Raven Press, New York) p. 783.
33. Porsolt, R.D., G. Anton, N. Blavet and M. Jalfre, 1978, Behavioral despair in rats: A new model sensitive to antidepressant treatments, Eur. J. Pharmacol. 47, 379.
34. 1A receptor ligands in the chronic mild stress model of depression, Neuropharmacology 34, 1305.
35. Rundfeldt, C., P. Wlaz and W. Löscher, 1994, Anticonvulsant activity of antagonists and partial agonists for the NMDA receptor-associated glycine site in the kindling model of epilepsy. Brain Res. 653, 125.
36. Skolnick, P., J. Marvizon, B. Jackson, J. Moon, K. Rice and A. Lewin, 1989, Blockade of N-methyl-D-aspartate induced convulsions by 1-aminocyclopropanecarboxylates, Life Sci. 45, 1647.
37. Skolnick, P., R. Miller, A. Young, K. Boje and R. Trullas, 1992, Chronic treatment with 1-aminocyclopropanecarboxylic acid desensitizes behavioral responses to compounds acting at the NMDA receptor complex, Psychopharmacology 107, 489.
38. Skolnick, P., R.T. Layer, R. Trullas, P. Popik, G. Nowak and I.A. Paul, 1996, Adaptation of N-methyl-D-aspartate (NMDA) receptors following antidepressant treatments: Implications for the pharmacotherapy of depression, Pharmacopsychiatry 29, 23.
39. Sveinbjornsdottir, S., J.W.A.S. Sander, D. Upton, P.J. Thompson, P.N. Patsalos, D. Hirt, M. Emre, D. Lowe and J.S. Duncan, 1993, The excitatory amino acid antagonist D-CPP-ene (Sdz Eaa-494) in patients with epilepsy, Epilepsy Res. 16, 165.
40. Trullas, R., B. Jackson and P. Skolnick, 1989, Anxiolytic properties of 1-aminocyclopropanecarboxylic acid, a ligand at strychnine-insensitive glycine receptors, Pharmacol. Biochem. Behav. 34, 313.
41. Trullas, R. and P. Skolnick, 1990, Functional antagonists at the NMDA receptor complex exhibit antidepressant actions, Eur. J. Pharmacol. 185, 1.
42. Trullas, R., T. Folio, A. Young, R. Miller, K. Boje and P. Skolnick, 1991, 1-aminocyclopropanecarboxylates exhibit antidepressant and anxiolytic actions in animal models, Eur. J. Pharmacol. 203, 379.
43. Watson, G.B. and T.H. Lanthorn, 1990, Pharmacological characteristics of cyclic homologous of glycine at the N-methyl-D-aspartate receptor-associated glycine site, Neuropharmacology 29, 727.
44. Willner, P., 1991, Animal models as simulations of depression, TIPS 12, 131.
45. Willner, P., R. Muscat and M. Papp, 1992, Chronic mild stress-induced anhedonia: A realistic animal model of depression, Neurosci. Biobehav. Rev. 16, 525.
46. Winslow, J.T., T.R. Insel, R. Trullas and P. Skolnick, 1990, Rat pup isolation calls are reduced by functional antagonists of the NMDA receptor complex, Eur. J. Pharmacol. 190, 11-21.